Delivery Order SPE2DB22D3401-SPE2DB25FT4DQ
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Activase 100 mg vials, a thrombolytic medication used in acute medical emergencies. The contract carries a ceiling value of $40,242.90 and represents a firm fixed-price delivery order with an ultimate completion date of December 9, 2025. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,935.94 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical situations. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $18,607.87 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This competitive award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,897.59 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract, awarded December 19, 2025, carries a firm fixed price structure with an ultimate completion date of December 22, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a $36,187.73 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical treatment. This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,839.85 delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, with an ultimate completion date of June 9, 2025. This firm fixed price contract represents a non-set-aside competitive award issued on June 6, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency awarded a $30,597.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designations, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $41,433.56 to supply 100 mg vials of Activase, a thrombolytic medication used to treat acute myocardial infarction and other thrombotic conditions. This firm fixed-price delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office...